All Stories

  1. OPG and TNFR1 as Potential Biomarkers of Inflammation in Older Adults with Acute COVID-19 and Indicators of Frailty in Post-COVID-19: A Pilot Study
  2. Systemic Inflammation Indices as Early Predictors of Severity in Acute Pancreatitis
  3. EWAS in COPD by biomass-burning smoke exposure identifies low levels of endothelin-1 by hypermethylation of EDN1
  4. Association of Vitamin D Supplementation with Glutathione Peroxidase (GPx) Activity, Interleukine-6 (IL-6) Levels, and Anxiety and Depression Scores in Patients with Post-COVID-19 Condition
  5. Biomass Smoke Exposure Reduces DNA Methylation Levels in PRSS23 (cg23771366) in Women with Chronic Obstructive Pulmonary Disease
  6. Genetic Variants in Genes Related to Lung Function and Interstitial Lung Diseases Are Associated with Worse Outcomes in Severe COVID-19 and Lung Performance in the Post-COVID-19 Condition
  7. IgG4-RD-Associated Mikulicz Syndrome Without Classic Systemic Involvement—A Case Report
  8. TNF/IFN-γ Co-Signaling Induces Differential Cellular Activation in COVID-19 Patients: Implications for Patient Outcomes
  9. MUC5B rs35705950 Promoter Variant Is Associated with Usual Interstitial Pneumonia in Patients with Antisynthetase Syndrome
  10. Variants rs3804099 and rs3804100 in the TLR2 Gene Induce Different Profiles of TLR-2 Expression and Cytokines in Response to Spike of SARS-CoV-2
  11. Tongue Tuberculosis as a Complication of Pott’s Disease in a Patient on Systemic Steroid Therapy without Pulmonary Tuberculosis
  12. Matrix metalloprotease-7 is associated with post-COVID persistent lung abnormalities.
  13. The Immune Response of OAS1, IRF9, and IFI6 Genes in the Pathogenesis of COVID-19
  14. HLA-G14-bp variant is associated with exercise-induced oxygen desaturation in the post-COVID-19 condition
  15. The type 2 inflammatory response favors recognition of tumor antigens by IgE in breast cancer
  16. Variant rs4986790 of toll-like receptor 4 affects the signaling and induces cell dysfunction in patients with severe COVID-19
  17. Single-Nucleotide Variants in PADI2 and PADI4 and Ancestry Informative Markers in Interstitial Lung Disease and Rheumatoid Arthritis among a Mexican Mestizo Population
  18. Peptidyl Arginine Deiminases in Chronic Diseases: A Focus on Rheumatoid Arthritis and Interstitial Lung Disease
  19. Changes in lifestyle and physical and mental health related to long-confinement due COVID-19: a study during the first and second pandemic waves in Mexico and Chile
  20. Participation of Single-Nucleotide Variants in IFNAR1 and IFNAR2 in the Immune Response against SARS-CoV-2 Infection: A Systematic Review
  21. Single-Nucleotide Variants in PADI2 and PADI4 and Ancestry Informative Markers in Interstitial Lung Disease and Rheumatoid Arthritis among a Mexican Mestizo Population
  22. Molecular Factors in PAD2 (PADI2) and PAD4 (PADI4) Are Associated with Interstitial Lung Disease Susceptibility in Rheumatoid Arthritis Patients
  23. Lung Function and Asthma Clinical Control in N-ERD Patients, Three-Year Follow-Up in the Context of Real-World Evidence
  24. High Expression Levels of miR-21-5p in Younger Hospitalized COVID-19 Patients Are Associated with Mortality and Critical Disease
  25. The rs16969968 Tobacco Smoking-Related Single-Nucleotide Variant Is Associated with Clinical Markers in Patients with Severe COVID-19
  26. The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients
  27. Exploring the potential benefits of pharmacogenomics in chronic respiratory diseases
  28. Characterization of the lung microbiome and inflammatory cytokine levels in women exposed to environmental risk factors: A pilot study
  29. Serum Levels of IFABP2 and Differences in Lactobacillus and Porphyromonas gingivalis Abundance on Gut Microbiota Are Associated with Poor Therapeutic Response in Rheumatoid Arthritis: A Pilot Study
  30. SNPs Sets in Codifying Genes for Xenobiotics-Processing Enzymes Are Associated with COPD Secondary to Biomass-Burning Smoke
  31. Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome
  32. Current pharmacogenomic recommendations in chronic respiratory diseases: Is there a biomarker ready for clinical implementation?
  33. The HLA-DRB1*07 Allele Is Associated with Interstitial Lung Abnormalities (ILA) and Subpleural Location in a Mexican Mestizo Population
  34. Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure
  35. COVID-19 Survivor Patients Carrying the Rs35705950 Risk Allele in MUC5B Have Higher Plasma Levels of Mucin 5B
  36. Interstitial lung disease progression in patients with Anti-aminoacyl Transfer-RNA-Synthetase Autoantibodies is characterized by higher levels of sCD163.
  37. SERPINE1 rs6092 Variant Is Related to Plasma Coagulation Proteins in Patients with Severe COVID-19 from a Tertiary Care Hospital
  38. TNFRSF1B and TNF variants are associated with differences in soluble TNF receptors' levels in patients with severe COVID-19
  39. Circulating Levels of PD-L1, TIM-3 and MMP-7 Are Promising Biomarkers to Differentiate COVID-19 Patients That Require Invasive Mechanical Ventilation
  40. CD4+/IL‑4+ lymphocytes of the lamina propria and substance P promote colonic protection during acute stress
  41. Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2
  42. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression
  43. Hypomethylation of AHRR (cg05575921) Is Related to Smoking Status in the Mexican Mestizo Population
  44. Cigarette Smoking Alters the Expression of Circulating microRNAs and Its Potential Diagnostic Value in Female Lung Cancer Patients
  45. Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
  46. Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality
  47. PADI2 Polymorphisms Are Significantly Associated With Rheumatoid Arthritis, Autoantibodies Serologic Status and Joint Damage in Women from Southern Mexico
  48. Protective Role of Genetic Variants in HSP90 Genes-Complex in COPD Secondary to Biomass-Burning Smoke Exposure and Non-Severe COPD Forms in Tobacco Smoking Subjects
  49. The “Slow Horse Racing Effect” on Lung Function in Adult Life in Chronic Obstructive Pulmonary Disease Associated to Biomass Exposure
  50. Molecular analysis of phenotypic interactions of asthma
  51. Genetic Variants in Smoking-Related Genes in Two Smoking Cessation Programs: A Cross-Sectional Study
  52. Clinical Markers of Chronic Hypoxemia in Respiratory Patients Residing at Moderate Altitude
  53. Lung Damage Caused by Heated Tobacco Products and Electronic Nicotine Delivery Systems: A Systematic Review
  54. Multidrug-resistant tuberculosis patients expressing the HLA-DRB1*04 allele, and after treatment they show a low frequency of HLA-II+ monocytes and a chronic systemic inflammation
  55. Genetics Insight for COVID-19 Susceptibility and Severity: A Review
  56. Genetic Factors Associated with COPD Depend on the Ancestral Caucasian/Amerindian Component in the Mexican Population
  57. Pharmacogenetics Approach for the Improvement of COVID-19 Treatment
  58. Single Nucleotide Polymorphism in the IL17A Gene Is Associated with Interstitial Lung Disease Positive to Anti-Jo1 Antisynthetase Autoantibodies
  59. Role of the Host Genetic Susceptibility to 2009 Pandemic Influenza A H1N1
  60. Genetic Susceptibility to Antisynthetase Syndrome Associated With Single-Nucleotide Variants in the IL1B Gene That Lead Variation in IL-1β Serum Levels
  61. Polymorphisms in Processing and Antigen Presentation-Related Genes and Their Association with Host Susceptibility to Influenza A/H1N1 2009 Pandemic in a Mexican Mestizo Population
  62. The SNP rs13147758 in the HHIP Gene Is Associated With COPD Susceptibility, Serum, and Sputum Protein Levels in Smokers
  63. Participation of HHIP Gene Variants in COPD Susceptibility, Lung Function, and Serum and Sputum Protein Levels in Women Exposed to Biomass-Burning Smoke
  64. Lung Microbiome Participation in Local Immune Response Regulation in Respiratory Diseases
  65. Methotrexate and rheumatoid arthritis associated interstitial lung disease
  66. Smoke exposure from chronic biomass burning induces distinct accumulative systemic inflammatory cytokine alterations compared to tobacco smoking in healthy women
  67. Anti-Aminoacyl Transfer-RNA-Synthetases (Anti-tRNA) Autoantibodies Associated with Interstitial Lung Disease: Pulmonary Disease Progression has a Persistent Elevation of the Th17 Cytokine Profile
  68. HLA in hypersensitivity pneumonitis patients positives to autoantibodies
  69. Heterozygous Genotype rs17580 AT (PiS) in SERPINA1 is Associated with COPD Secondary to Biomass-Burning and Tobacco Smoking: A Case–Control and Populational Study
  70. Single Nucleotide and Copy-Number Variants in IL4 and IL13 Are Not Associated with Asthma Susceptibility or Inflammatory Markers: A Case-Control Study in a Mexican-Mestizo Population
  71. Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease
  72. Genetic variants in IL17A and serum levels of IL-17A are associated with COPD related to tobacco smoking and biomass burning
  73. HLA Allele and Haplotype Frequencies in Three Urban Mexican Populations: Genetic Diversity for the Approach of Genomic Medicine
  74. Effect of SNPs in HSP Family Genes, Variation in the mRNA and Intracellular Hsp Levels in COPD Secondary to Tobacco Smoking and Biomass-Burning Smoke
  75. IL10 rs1800872 Is Associated with Non-Steroidal Anti-Inflammatory Drugs Exacerbated Respiratory Disease in Mexican-Mestizo Patients
  76. The VNTR 48 bp Polymorphism in the DRD4 Gene Is Associated with Higher Tobacco Smoking in Male Mexican Mestizo Smokers with and without COPD
  77. Haplotype in SERPINA1 (AAT) Is Associated with Reduced Risk for COPD in a Mexican Mestizo Population
  78. Participation of the miR-22-HDAC4-DLCO Axis in Patients with COPD by Tobacco and Biomass
  79. miR-34a in serum is involved in mild-to-moderate COPD in women exposed to biomass smoke
  80. MMP2 Polymorphism Affects Plasma Matrix Metalloproteinase (MMP)-2 Levels, and Correlates with the Decline in Lung Function in Hypersensitivity Pneumonitis Positive to Autoantibodies Patients.
  81. Evolution of Pulmonary Function in a Cohort of Patients with Interstitial Lung Disease and Positive for Antisynthetase Antibodies
  82. Corrigendum to “Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer” [Crit. Rev. Oncol. Hematol. 137, May (2019) 57–83]
  83. Data on genotype frequency for SNPs associated to age of smoking onset and successful smoking cessation treatment
  84. Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer
  85. A Mobile Smoking Cessation Intervention for Mexico (Vive sin Tabaco... ¡Decídete!): Single-Arm Pilot Study
  86. Genetic variants as risk factors for cigarette smoking at an early age and relapse to smoking cessation treatment: A pilot study
  87. Role of Genetic Susceptibility in Nicotine Addiction and Chronic Obstructive Pulmonary Disease
  88. Allergic sensitization increases the amount of extracellular ATP hydrolyzed by guinea pig leukocytes
  89. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
  90. Influence of proinflammatory cytokine gene polymorphisms on the risk of COPD and the levels of plasma protein
  91. A Mobile Smoking Cessation Intervention for Mexico (Vive sin Tabaco... ¡Decídete!): Single-Arm Pilot Study (Preprint)
  92. Genetic variant in MMP2 increases the risk to develop autoantibodies in patients with Hypersensitivity Pneumonitis
  93. HTR2A genetic variants as risk factors for cigarette smoking at an early age and relapse to smoking cessation treatment.
  94. HLA class II alleles and haplotypes are associated to the presence autoantibodies and mortality in Hypersensitivity Pneumonitis patients.
  95. MS4A2-rs573790 Is Associated With Aspirin-Exacerbated Respiratory Disease: Replicative Study Using a Candidate Gene Strategy
  96. Chronic infection with Mycobacterium lepraemurium induces alterations in the hippocampus associated with memory loss
  97. OP0284 Muc5b promoter variant rs35705950 is a risk factor for rheumatoid arthritis – interstitial lung disease
  98. Prevalence of COPD and respiratory symptoms associated with biomass smoke exposure in a suburban area
  99. TNF promoter polymorphisms are associated with genetic susceptibility in COPD secondary to tobacco smoking and biomass burning
  100. Genetic polymorphisms and their involvement in the regulation of the inflammatory response in asthma and COPD
  101. Class I HLA alleles are associated with influenza A H1N1 susceptibility.
  102. Single nucleotide polymorphisms in TNF are associated with susceptibility to aspirin-exacerbated respiratory disease but not to cytokine levels: a study in Mexican mestizo population
  103. Data on polymorphisms in CYP2A6 associated to risk and predispose to smoking related variables
  104. Physiopathology and genetics in aspirin-exacerbated respiratory disease
  105. NTPDase activity in circulatory eosinophils from patients with allergic asthma
  106. Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages
  107. Comparison of HSP mRNA relative levels in sputum of COPD patients and subjects exposed to wood smoke and/or cigarette smoke
  108. Heterozygous genotype rs17580 AT (PiS) in SERPINA1 is associated to COPD secondary to biomass and tobacco smoke
  109. Mediadores de la respuesta inflamatoria en asma y su relación con obesidad
  110. Participation of Th17 mediators in COPD exacerbations
  111. Polymorphisms in HTR2A and DRD4 Predispose to Smoking and Smoking Quantity
  112. SNPs in NRXN1 and CHRNA5 are associated to smoking and regulation of GABAergic and glutamatergic pathways
  113. Genetic Variants inIL6RandADAM19are Associated with COPD Severity in a Mexican Mestizo Population
  114. Association of TRPM3 Polymorphism (rs10780946) and Aspirin-Exacerbated Respiratory Disease (AERD)
  115. TNF, IL6, and IL1B Polymorphisms Are Associated with Severe Influenza A (H1N1) Virus Infection in the Mexican Population
  116. Chronic obstructive pulmonary disease induced by exposure to biomass smoke is associated with a Th2 cytokine production profile
  117. Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers
  118. Genetic polymorphisms of matrix metalloproteinases and protein levels in chronic obstructive pulmonary disease in a Mexican population
  119. Genetic variants inNRXN1,CHRNA3,CHRNA5andCHRNB4are associated with smoking and increased consumption of cigarettes per day in a Mexican mestizo population
  120. TNFpromoter polymorphisms are associated with susceptibility and increased severity in secondary to tobacco and biomass smoke COPD in Mexican population
  121. Identification of genetic variants in the TNF promoter associated with COPD secondary to tobacco smoking and its severity
  122. Prevalence of Alpha-1 Antitrypsin High-risk Variants in Mexican Mestizo Population and Their Association With Lung Function Values
  123. Prevalencia de variantes de alto riesgo de alfa-1 antitripsina en población mestiza mexicana y su relación con los valores de la función pulmonar
  124. HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients
  125. Glucose and glutamine metabolism control by APC and SCF during the G1-to-S phase transition of the cell cycle
  126. Genetic susceptibility to multicase hypersensitivity pneumonitis is associated with the TNF-238 GG genotype of the promoter region and HLA-DRB1*04 bearing HLA haplotypes
  127. HLA Class II Alleles in the Otomi Population of the Mezquital Valley: A Genetic Approach to the History of Interethnic Migrations in the Mexican Central Plateau
  128. Genetic polymorphism of tumor necrosis factor promoter region and susceptibility to develop Hodgkin lymphoma in a Mexican population
  129. Biochemical pathogenesis of aspirin exacerbated respiratory disease (AERD)
  130. Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCLpolymorphisms in Mexican population: a case–control study
  131. 288 IL1B but not IL8 Polymorphisms Are Increased in Aspirin Exacerbated Respiratory Disease Patients Versus Aspirin Tolerant Asthmatics
  132. The IL1B-511 Polymorphism (rs16944 AA Genotype) Is Increased in Aspirin-Exacerbated Respiratory Disease in Mexican Population
  133. Sleep, Fatigue, Depression, and Pain in Mexican Women With Systemic Lupus Erythematosus: An Exploratory Study
  134. PSMB8 (LMP7) but not PSMB9 (LMP2) gene polymorphisms are associated to pigeon breeder's hypersensitivity pneumonitis
  135. MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility
  136. Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis
  137. Major Histocompatibility Complex and Tumor Necrosis Factor- α Polymorphisms in Pigeon Breeder's Disease